Who is sponsoring NCT05175612?

NCT05175612 is sponsored by Healthy Networks.

What drugs are being tested in NCT05175612?

Interventions in NCT05175612: Lung auscultation with LungPass device (electronic auscultation).

What condition does NCT05175612 study?

NCT05175612 studies Acute Respiratory Tract Infection.

Is NCT05175612 still recruiting?

NCT05175612 is currently suspended. Last updated 7 June 2022.

Last reviewed 2022-06-07 · How we verify

NCT05175612

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Differentiation of Upper and Lower Respiratory Tract Infections Using Automated Lung Sound Analysis With LungPass Device

Suspended Last updated 7 June 2022

What this trial tests

trial testing Lung auscultation with LungPass device (electronic auscultation) in Acute Respiratory Tract Infection in 400 participants. Suspended.

Timeline

16 November 2021

Primary endpoint
30 November 2022

30 November 2022

Quick facts

Lead sponsor	Healthy Networks
Status	Suspended
Study type	OBSERVATIONAL
Enrollment	400
Start date	16 November 2021
Primary completion	30 November 2022
Estimated completion	30 November 2022
Sites	1 location across Belarus

Drugs / interventions tested

Lung auscultation with LungPass device (electronic auscultation)

Conditions studied

Acute Respiratory Tract Infection — all drugs for Acute Respiratory Tract Infection →

Sponsor

Healthy Networks

Who can join

3 and older, any sex, with Acute Respiratory Tract Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This observational study evaluates whether lung sound analysis with LungPass device can be used to differentiate upper and lower respiratory tract infections (URTI and LRTI)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lung auscultation with LungPass device (electronic auscultation)

Trials testing the same drug.

NCT05145894 — Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device · unknown

Other recruiting trials for Acute Respiratory Tract Infection

Currently open trials in the same condition.

NCT05814237 — POS-ARI-ER Observational Study of Acute Respiratory Infections · recruiting

Other Healthy Networks trials

Trials by the same sponsor.

NCT05145894 — Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05175612 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Healthy Networks
Last refreshed: 7 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05175612.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing